DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.03% | 15.54% | 16.15% | 15.60% | 14.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.03% | 15.54% | 16.15% | 15.60% | 14.21% |
| Cost of Revenue | 0.87% | 5.15% | 10.22% | 16.64% | 22.17% |
| Gross Profit | 21.48% | 22.83% | 20.20% | 14.92% | 9.27% |
| SG&A Expenses | 8.37% | 7.03% | 4.23% | 0.40% | 2.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.81% | 5.99% | 7.65% | 9.24% | 12.39% |
| Operating Income | 57.36% | 65.76% | 63.36% | 51.97% | 23.84% |
| Income Before Tax | 31.64% | 63.24% | 64.70% | 53.51% | 28.92% |
| Income Tax Expenses | 13.89% | 31.84% | 39.67% | 89.83% | 277.65% |
| Earnings from Continuing Operations | 37.51% | 74.93% | 73.84% | 45.14% | 5.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.51% | 74.93% | 73.84% | 45.14% | 5.86% |
| EBIT | 57.36% | 65.76% | 63.36% | 51.97% | 23.84% |
| EBITDA | 46.64% | 51.98% | 50.65% | 42.30% | 21.62% |
| EPS Basic | 40.88% | 77.41% | 76.13% | 46.45% | 5.66% |
| Normalized Basic EPS | 47.96% | 55.42% | 54.61% | 43.90% | 18.43% |
| EPS Diluted | 42.00% | 77.35% | 75.52% | 46.92% | 7.71% |
| Normalized Diluted EPS | 50.38% | 57.30% | 55.85% | 45.10% | 20.58% |
| Average Basic Shares Outstanding | -2.31% | -1.46% | -1.28% | -0.84% | -0.18% |
| Average Diluted Shares Outstanding | -3.91% | -2.61% | -2.02% | -1.72% | -1.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |